The Funds are distributed by First Trust Portfolios L.P., an affiliate of First Trust Capital Management L.P
Unlike compounds designed for direct therapeutic outcomes, BPC-157 peptide serves strictly as a research tool
These findings have contributed to GHK-Cu becoming one of the more frequently studied peptides in dermatological and follicular biology research
However, loss of TJ adhesion in later pathology may have the opposite effect, which may partly explain disparate results across studies, in which decreased water transfer to the hippocampus, caudate, and thalamus in AD patients was inconsistently observed (Montagne et al., 2016a
What we are developing could be used as something like maintenance therapy where you could get subcutaneous injections every 3 to 6 months. The market opportunity also resulted in a dramatic legal battle between Pfizer and Novo Nordisk last year, when the two companies fought over buying Metsera, a start-up developing weight-loss drugs
Alexis Granite, MD, is a board-certified dermatologist in America and England